S&P 500 Gains as AI and Rate Hikes Take Center Stage for Investors
The S&P 500 (Index: SPX) showed off the dueling forces of the ongoing AI boom and the rising likelihood of interest rate hikes affecting the direction of the U.S. stock market in the Juneteenth holiday-shortened trading week. Despite rising and falling during the week, the index ultimately ended up 0.9% at 7,500.58 as the prospect of gains from rapidly advancing AI technologies edged out the expected higher cost of borrowing for the firms making those big investments.
That outcome came after the a hawkish Fed sent stock prices falling on Wednesday, 17 June 2026 as expectations for two rate hikes in 2026 took hold. The CME Group’s FedWatch Tool has moved up the expected timing of a quarter point increase in the Federal Funds Rate to a target range of 3.75-4.00% three months earlier, now expected the move to happen after the Fed meets on 16 September (2026-Q3). The FedWatch tool also now anticipates a second quarter point rate hike on 9 December (2026-Q4).
There was some good news, in that the FedWatch tool no longer suggests a bias toward rate hikes in 2027 and even sees the potential for a quarter point rate cut by October (2027-Q4).
With the end of 2026-Q2 now in the past from a dividend futures perspective, investors look to have shifted their forward-looking focus away from the effectively ended quarter of 2026-Q2 to the distant future quarter of 2026-Q4 in setting current day stock prices. The latest update of the alternative futures chart shows the trajectory of the S&P 500 is most closely paralleling the dividend futures-based model‘s projected trajectory associated with investors setting their attention on 2026-Q4.
There was one other market moving event that had outsize influence over the direction of stock prices during the week that was. The U.S. and Iran reached an agreement to continue their ceasefire into November 2026 while they continue negotiating, which provided the momentume for the market’s gains on Monday. In the absence of other developments related to that geopolitical event, we anticipate its influence will continue waning.
Here are the market moving headlines for the week that was:
- Monday, 15 June 2026
-
- Signs and portents for the U.S. economy:
- Trump announces US and Iran have reached peace deal — here’s when the Strait of Hormuz reopens, and what happens next
- Treasury yields slide as Iran deal drives rethink on Fed interest rate hikes
- U.S. crude drops below $80 for the first time since March as Iran deal is set to open Hormuz Strait
- Bigger trouble, stimulus developing in China:
- BOJ minions still gung-ho to hike Japan’s interest rates, thinking about what more they need to do to bailout Japan’s currency:
- Iran peace deal won’t change BOJ’s rate-hike plans, ex-central bank economist says
- Why an Iran peace deal won’t pull the yen back from the brink
- ECB minions thinking they might need to hike Eurozone interest rates again:
- ECB needs to do more to contain inflation pressures, Kazimir says
- ECB’s Nagel says no inflation relief in sight even if Hormuz Strait reopens soon
- ECB’s Lagarde welcomes Iran deal but inflation fears linger
- Wall Street rallies, Dow ends with record on US-Iran deal, oil price slide
- Tuesday, 16 June 2026
-
- Signs and portents for the U.S. economy:
- Oil prices fall 5% to 3-month low on hopes Strait of Hormuz will open
- Bigger trouble developing in China:
- China’s economic imbalance deepens as retail sales fall for first time in over three years
- China’s new home prices fall at faster pace in May on soft demand
- China’s EV Price War Was Built On Cars Sold At A Loss
- BOJ minions act on long-held ambition to keep hiking Japan’s interest rates:
- BOJ Policy Shift: Rates lifted to 31-year high of 1.0% to counter war-driven energy inflation
- BOJ Deputy Governor Uchida’s comments at news conference
- Bank Of Japan Raises Rates To 1% For The First Time In 31 Years, Will Stop Reducing Bond Purchases
- ECB minions getting excited thinking about next Eurozone rate hikes:
- ECB will be proactive against high inflation even after Iran deal, Lane says
- Price pressures may linger due to damaged energy assets, ECB’s Makhlouf says
- Bigger trouble developing in the Eurozone:
- Nasdaq and S&P 500 slip while Dow hits record close
- Wednesday, 17 June 2026
-
- Signs and portents for the U.S. economy:
- Container imports soar at busiest US port in May as buyers try to outrun rising fuel costs
- Oil rises 1% on US-Iran deal doubts; IEA warns of supply glut
- Cushing Stocks Crash To ‘Tank Bottoms’, Seasonally Lowest Since 2005; SPR Sees Another Huge Drain
- Trump Admits US Was Weeks Away From “Running Out Of Reserves” When Iran Deal Struck
- Fed minions hold Federal Funds Rate steady as expected, but sets expectation for rate hike later in 2026; new chief minion plans to shake up Fed’s operations:
- Fed Holds Rates Unchanged (As Expected), ‘Dots’ Signal Hawkish Bias As Warsh Takes Over
- VIEW Fed holds steady in Warsh’s debut, but hawkish shift fuels bond-market rout
- Traders now see Fed raising rates by September
- Nearly half of Fed policymakers see a 2026 rate hike in the cards
- Fed chief Warsh skips rate-path ‘dot,’ launches communications review
- Investors brace for less predictable Fed as Warsh rewrites playbook
- Bigger stimulus developing in China:
- BOJ minions worried about inflation/falling value of currency in Japan, fueling plan to keep hiking Japan’s interest rates:
- BOJ deputy’s brief moment at the helm reveals deeper inflation anxiety
- Japan’s exports rise on weak yen, AI boom, but price-led gains mask weak volumes
- Bigger trouble developing in Eurozone:
- BMW lowers profit outlook due to China downturn, Iran war double whammy
- Volkswagen reduces production at German plant amid uncertain future for site
- Wall Street sinks on bets Fed will hike rates this year
- Thursday, 18 June 2026
-
- Signs and portents for the U.S. economy:
- Oil falls to lowest since start of Iran war after ceasefire deal signed
- Investors brace for less predictable Fed as Warsh rewrites playbook
- Bigger trouble, stimulus developing in China:
- China’s mid-year shopping festival highlights weak demand, rising role of AI
- PetroChina forecasts Chinese oil consumption will drop 4.9% this year
- BOJ/JapanGov minions getting set to bail out Japan’s currency:
- ECB minions getting excited thinking about more Eurozone rate hikes:
- ECB’s Lane hints at higher rates even after Iran shock
- ECB wage tracker shows muted pay pressure despite war inflation
- S&P 500 closes higher, Nasdaq climbs nearly 2% as chips fuel comeback from Fed sell-off
- Wall St indexes advance with boost from chips, Iran optimism
The Atlanta Fed’s GDPNow tool‘s estimate of real GDP growth for the U.S. economy in the current quarter of 2026-Q2 dipped to +3.0%, falling back from the previous week’s real growth estimate of +3.3%.
Image credit: Microsoft Copilot Designer. Prompt: “An editorial cartoon of a Wall Street bull wearing a T-shirt that says ‘AI BOOM’ and a bear wearing a shirt that says ‘RATE HIKES’ where the bull asks ‘WHICH ONE OF US IS GOING TO WIN?’”
Source: https://politicalcalculations.blogspot.com/2026/06/s-500-gains-as-ai-and-rate-hikes-take.html
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.


